PCSK9 and hyperlipidemia: Across all three mouse cohorts, rAAV8‐Pcsk9 produced similar reductions in LDLR protein levels (Figure S21a, Supporting Information) and similar degrees of hyperlipidemia (Figure S21b–e, Supporting Information).